CNBC-TV18 @CNBCTV18Live · 03 Sep 2026
#SuvenLife: Completes Phase-3 study of Masupirdine for AAD in US & Europe 🚩Alert: AAD is Agitation-associated with Alzheimer’s Dementia ▶️Phase-3 study topline results expected by May 2027 https://t.co/AEXDiUFo9U
7 588Views
2Likes
0Reposts
0Replies
0Quotes
0Bookmarks
Is that a lot?
1.00Ă—vs this author's median7 588 views is typical
40Percentile for this authorof 5 recent posts
0.11×vs 1M–10M median66 438 views is typical
0.53%Reachviews Ă· followers
0.03%Engagement rateof viewers reacted